Solventum Corp. (SOLV)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $15.07B
Last updated: Nov 17, 2026 at 4:34 PM ET
Solventum Corp. (SOLV) Statistics
Solventum (SOLV) has a market cap of $15.07B and an enterprise value of $19.68B. Its share count is down 2.01% from a year earlier.
Total Valuation
Enterprise value is 30.64% above the market cap, as debt exceeds cash.
| Market Cap | $15.07B |
|---|---|
| Enterprise Value | $19.68B |
| Latest price (Nov 17, 2026) | $86.06 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.8x and 3.1x.
| P/E Ratio | 12.2x |
|---|---|
| Forward P/E | 11.7x |
| P/S Ratio | 1.8x |
| Forward P/S | 1.8x |
| P/B Ratio | 3.1x |
| P/OCF Ratio | 48.6x |
| PEG Ratio | 1.3 |
Enterprise Valuation
Counting debt and cash, the company is valued at 20.6x EBITDA.
| EV / Earnings | 126.2x |
|---|---|
| EV / Sales | 2.4x |
| EV / EBITDA | 20.6x |
| EV / EBIT | 47.2x |
Price Statistics
The stock is up 13.75% over 52 weeks and trades 1.50% below its 50-day average.
| Beta (1Y) | 0.62 |
|---|---|
| 52-Week Change | +13.75% |
| 1-Month Change | +1.19% |
| 3-Month Change | -1.99% |
| 6-Month Change | +15.16% |
| Total Return (1Y) | +13.75% |
| Return vs SPY (1Y) | +0.37% |
| Max Drawdown (1Y) | -27.46% |
| Max Drawdown (3Y) | -39.98% |
| Sharpe Ratio (1Y) | 0.38 |
| Correlation with SPY (1Y) | 0.29 |
| 50-Day Average | $87.37 |
| 200-Day Average | $78.95 |
| 52-Week Range | $62.38 to $94.16 |
| RSI (14 Days) | 46.4 |
| Average Volume (20 Days) | 1.27M |
Financial Position
Current assets cover 1.03x current liabilities, and total debt is 1.05x shareholder equity.
| Current Ratio | 1.03x |
|---|---|
| Quick Ratio | 0.72x |
| Debt / Equity | 1.05x |
| Debt / EBITDA | 5.40x |
| Interest Coverage | 26.12x |
Returns and Efficiency
Return on invested capital is 3.88% and return on equity is 3.25% over the last 12 months.
| Return on Equity (ROE) | 3.25% |
|---|---|
| Return on Assets (ROA) | 1.10% |
| Return on Invested Capital (ROIC) | 3.88% |
| Return on Capital Employed (ROCE) | 3.94% |
| ROE (5Y Average) | 16.42% |
| ROA (5Y Average) | 8.82% |
| Asset Turnover | 0.58x |
| Inventory Turnover | 3.45x |
| Receivables Turnover | 5.78x |
| Cash Conversion Cycle | 94 days |
Taxes
Income tax took 8.19% of pretax income over the last 12 months.
| Income Tax (TTM) | $14.00M |
|---|---|
| Effective Tax Rate | 8.19% |
Scores
SOLV has an Altman Z-Score of 1.81, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.81 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $8.16B over the last 12 months is down 2.84% from the 12 months before.
| Revenue | $8.16B |
|---|---|
| Revenue Growth (YoY) | -2.84% |
| Gross Profit | $4.47B |
| Operating Income | $455.00M |
| Pretax Income | $171.00M |
| Net Income | $156.00M |
| EBITDA | $938.00M |
| EBIT | $417.00M |
| Reported EPS (TTM) | $7.05 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 33.90% of the $14.16B in total assets.
| Cash and Equivalents | $451.00M |
|---|---|
| Total Debt | $5.07B |
| Net Debt | $4.62B |
| Net Debt Per Share | $27.03 |
| Working Capital | $117.00M |
| Shareholder Equity | $4.80B |
| Book Value Per Share | $28.13 |
| Tangible Book Value | -$3.13B |
| Total Assets | $14.16B |
| Total Liabilities | $9.36B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $310.00M of capital spending, operating cash flow left $0 of free cash flow.
| Operating Cash Flow | $310.00M |
|---|---|
| Capital Expenditures | $310.00M |
| Free Cash Flow | $0 |
| FCF Per Share | -$0.69 |
| Depreciation and Amortization | $521.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 5.57%, against a 5-year average of 20.64%.
| Gross Margin | 54.78% |
|---|---|
| Operating Margin | 5.57% |
| Pretax Margin | 2.09% |
| Net Margin | 1.91% |
| EBITDA Margin | 11.49% |
| EBIT Margin | 5.11% |
| FCF Margin | 0.00% |
| Gross Margin (5Y Average) | 56.87% |
| Operating Margin (5Y Average) | 20.64% |
| Net Margin (5Y Average) | 15.06% |
Growth
Revenue grew 0.79% a year over 3 years.
| Revenue Growth (3Y CAGR) | +0.79% |
|---|---|
| Revenue Growth (5Y CAGR) | +2.72% |
| Operating Income Growth (3Y CAGR) | +8.81% |
| Book Value Per Share Growth (2Y CAGR) | -34.69% |
Dividends and Yields
SOLV does not pay a dividend.
| Earnings Yield | 8.20% |
|---|---|
| Buyback Yield | 2.74% |
| Shareholder Yield | 2.74% |
Peer Position
Against 11 similar companies, SOLV has the lowest P/E and the 11th highest P/S.
P/E RatioPeer median 20.7x
P/S RatioPeer median 3.1x
ROICPeer median 7.13%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.01%
| P/E Ratio | 12.2x vs 20.7x median |
|---|---|
| P/S Ratio | 1.8x vs 3.1x median |
| ROIC | 3.88% vs 7.13% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -2.84% vs +9.01% median |
Analyst Forecast
Consensus estimates put revenue growth at 1.41% and EPS growth at 11.21% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +1.41% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +11.21% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SOLV
What is SOLV's market cap?
Solventum has a market cap of $15.07B. Its enterprise value, which adds debt and subtracts cash, is $19.68B.
What is SOLV's P/E ratio?
Solventum has a trailing P/E ratio of 12.2x and a forward P/E of 11.7x.
How many shares of SOLV are outstanding?
Solventum has 170.80M shares outstanding. The count is down 2.01% from a year earlier.
Does SOLV pay a dividend?
No. Solventum does not pay a dividend.
How much debt does SOLV have?
Solventum has $5.07B of total debt and $451.00M of cash and equivalents, a net debt position of $4.62B.
SOLV pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors